RECURRENT HAIRY CELL LEUKEMIA
Clinical trials for RECURRENT HAIRY CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HAIRY CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested to control Tough-to-Treat blood cancer
Disease control OngoingThis study is testing a daily pill called ibrutinib for people with hairy cell leukemia that has returned after previous treatment. The goal is to see if the drug can control the cancer by blocking a protein that helps the cancer cells grow. Researchers will measure how well pati…
Matched conditions: RECURRENT HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists re-engineer Patient's own cells to hunt down blood cancers
Disease control OngoingThis early-stage study is testing a new type of cellular immunotherapy for adults whose B-cell lymphoma or leukemia has come back. Doctors collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer cells, and then infuse them back…
Matched conditions: RECURRENT HAIRY CELL LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC